Show simple item record

dc.rights.licenseCC-BY-NC-ND
dc.contributor.advisorvan Goch, M
dc.contributor.advisorDavys, E
dc.contributor.authorSwart, N.
dc.date.accessioned2017-09-04T17:03:07Z
dc.date.available2017-09-04T17:03:07Z
dc.date.issued2016
dc.identifier.urihttps://studenttheses.uu.nl/handle/20.500.12932/27226
dc.description.abstractThis research answers the question how the prices of patented medicines can be lowered in Europe. An interdisciplinary approach is used to answer this complex question. Both economic and social sciences are used to get a more comprehensive understanding. This studies showed that the prices of medicines should be made public to enhance price-negotiations. But to enhance the lowering of prices, the patient's decision is an important factor to accomplish this. When the patient is involved in the decision-making regarding medication, it is possible to let the patients make a more informed and rational decision.
dc.description.sponsorshipUtrecht University
dc.format.extent1003229
dc.format.mimetypeapplication/pdf
dc.language.isoen
dc.titlePriceless Medicine How can the prices of patented medicines be lowered?
dc.type.contentBachelor Thesis
dc.rights.accessrightsOpen Access
dc.subject.courseuuLiberal Arts and Sciences


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record